133 related articles for article (PubMed ID: 377929)
1. The UGDP and the FDA audit.
Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929
[No Abstract] [Full Text] [Related]
2. [Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabetics?].
Simon M; Kissel T
Pharm Unserer Zeit; 2001; 30(2):136-41. PubMed ID: 11279984
[No Abstract] [Full Text] [Related]
3. Drug safety. Planned study of Avandia in doubt after FDA review.
Kean S
Science; 2010 Jul; 329(5990):375. PubMed ID: 20651123
[No Abstract] [Full Text] [Related]
4. "Settling the UGDP controversy"?
Bradley RF; Dolger H; Forsham PH; Seltzer H
JAMA; 1975 May; 232(8):813-7. PubMed ID: 1091759
[No Abstract] [Full Text] [Related]
5. The oral hypoglycemic controversy. Stay as sweet as you are.
Gregory DR
Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
[No Abstract] [Full Text] [Related]
6. [Treatment of diabetes mellitus with a mixture of oral hypoglycemic agents].
Quibrera R; Nava M; Grimaldo JI
Gac Med Mex; 1979 Mar; 115(3):121-6. PubMed ID: 378748
[No Abstract] [Full Text] [Related]
7. Insulin and oral hypoglycemic agents.
Price MJ
Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
[No Abstract] [Full Text] [Related]
8. FDA upholds findings of UGDP study.
JAMA; 1979 Jan; 241(1):17-8. PubMed ID: 758481
[No Abstract] [Full Text] [Related]
9. What went wrong? A retrospective on Exubera.
Baran MK; Godoy AT
Adv Nurse Pract; 2008 Nov; 16(11):53-4, 77. PubMed ID: 19999057
[No Abstract] [Full Text] [Related]
10. The unsettling UGDP controversy.
Sackler AM
JAMA; 1980 Apr; 243(14):1435-6. PubMed ID: 6987429
[No Abstract] [Full Text] [Related]
11. [What is new in the treatment of diabetes mellitus?].
Gain T
Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
[No Abstract] [Full Text] [Related]
12. Oral antidiabetics: philosophy and politics.
Bowen AJ
J Med Assoc Ga; 1976 Nov; 65(11):411-4. PubMed ID: 993676
[No Abstract] [Full Text] [Related]
13. The FDA and hypoglycemic drugs.
Davidson JK
JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
[No Abstract] [Full Text] [Related]
14. [Possibilities and limits of oral diabetes therapy].
Bruneder H
Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
[No Abstract] [Full Text] [Related]
15. [Intensive insulin therapy: results after ten years].
Laube H
Pharm Unserer Zeit; 2001 Jan; 30(1):40-5. PubMed ID: 11233182
[No Abstract] [Full Text] [Related]
16. Diabetes medications update.
Childs BP
Kans Nurse; 2004 May; 79(5):4-6. PubMed ID: 15216607
[No Abstract] [Full Text] [Related]
17. Geriatric pharmacology: drugs used in the management of diabetes mellitus.
Cuddy ML
J Pract Nurs; 2004; 54(4):18-23; quiz 24-5. PubMed ID: 15730185
[No Abstract] [Full Text] [Related]
18. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
[No Abstract] [Full Text] [Related]
19. [A new aspect in diabetes treatment. Results of an orally administered insulin mimetic].
Winckler T
Pharm Unserer Zeit; 2001; 30(2):131-4. PubMed ID: 11279983
[No Abstract] [Full Text] [Related]
20. Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitus.
Hennekens CH; Hebert PR; Schneider WR; O'Brien P; Demets D; Borer JS
Contemp Clin Trials; 2010 Sep; 31(5):411-3. PubMed ID: 20601161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
